FREDUN PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of FREDUN PHARMACEUTICALS have increased by 22.37% YoY .
The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 66.83 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
FREDUN PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539730]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹275 Cr | ₹224 Cr | ₹134 Cr | ₹113 Cr | ₹97 Cr |
| Expenses | ₹246 Cr | ₹211 Cr | ₹125 Cr | ₹104 Cr | ₹87 Cr |
| Operating Profit (Excl OI) | ₹29 Cr | ₹14 Cr | ₹9.35 Cr | ₹8.33 Cr | ₹10 Cr |
| Other Income | ₹1.84 Cr | ₹1.63 Cr | ₹1.40 Cr | ₹0.52 Cr | ₹0.58 Cr |
| Interest | ₹10 Cr | ₹4.78 Cr | ₹4.37 Cr | ₹4.48 Cr | ₹3.12 Cr |
| Depreciation | ₹2.81 Cr | ₹2.16 Cr | ₹2.00 Cr | ₹1.88 Cr | ₹1.33 Cr |
| Profit Before Tax | ₹18 Cr | ₹8.60 Cr | ₹3.21 Cr | ₹2.50 Cr | ₹6.16 Cr |
| Profit After Tax | ₹11 Cr | ₹6.34 Cr | ₹2.02 Cr | ₹1.90 Cr | ₹4.46 Cr |
| Consolidated Net Profit | ₹11 Cr | ₹6.34 Cr | ₹2.02 Cr | ₹1.90 Cr | ₹4.46 Cr |
| Earnings Per Share (Rs) | ₹23.84 | ₹14.29 | ₹5.05 | ₹4.77 | ₹11.18 |
| PAT Margin (%) | 3.93 | 2.82 | 1.50 | 1.69 | 4.60 |
| ROE(%) | 13.86 | 11.42 | 4.77 | 4.74 | 14.59 |
| ROCE(%) | 18.35 | 13.15 | 9.53 | 10.36 | 20.56 |
| Total Debt/Equity(x) | 0.98 | 0.78 | 0.92 | 0.84 | 0.49 |
Key Financials |
||
| Market Cap | : | ₹ 397.5 Cr |
| Revenue (TTM) | : | ₹ 310.8 Cr |
| Net Profit(TTM) | : | ₹ 14.5 Cr |
| EPS (TTM) | : | ₹ 30.8 |
| P/E (TTM) | : | 27.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FREDUN PHARMACEUTICALS | 10.5% | 15.3% | -3.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
| CIPLA | 4.1% | -4.8% | 55.6% |
| DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
| ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
| DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
| MANKIND PHARMA | 1.3% | 7% | NA |
| TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
| LUPIN | 0.6% | 0.5% | 127.2% |
FREDUN PHARMACEUTICALS Revenues
[BOM: 539730]
| Y-o-Y | 22.37 % |
| 5 Yr CAGR | 29.72 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹275 Cr | 22.37 | |
| Mar2022 | ₹224 Cr | 67.64 | |
| Mar2021 | ₹134 Cr | 18.73 | |
| Mar2020 | ₹113 Cr | 16.24 | |
| Mar2019 | ₹97 Cr | - | |
FREDUN PHARMACEUTICALS Operating Profit
[BOM: 539730]
| Y-o-Y | 107.22 % |
| 5 Yr CAGR | 30.20 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹29 Cr | 107.22 | |
| Mar2022 | ₹14 Cr | 48.83 | |
| Mar2021 | ₹9.35 Cr | 12.20 | |
| Mar2020 | ₹8.33 Cr | -16.94 | |
| Mar2019 | ₹10 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 69.19 % |
| 5 Yr CAGR | 0.36 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 10.49% | 69.19 | |
| Mar2022 | 6.2% | -11.17 | |
| Mar2021 | 6.98% | -5.55 | |
| Mar2020 | 7.39% | -28.53 | |
| Mar2019 | 10.34% | - | |
FREDUN PHARMACEUTICALS Profit After Tax
[BOM: 539730]
| Y-o-Y | 70.59 % |
| 5 Yr CAGR | 24.76 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹11 Cr | 70.59 | |
| Mar2022 | ₹6.34 Cr | 214.39 | |
| Mar2021 | ₹2.02 Cr | 5.94 | |
| Mar2020 | ₹1.90 Cr | -57.35 | |
| Mar2019 | ₹4.46 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 39.36 % |
| 5 Yr CAGR | -3.86 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 3.93 % | 39.36 | |
| Mar2022 | 2.82 % | 88.00 | |
| Mar2021 | 1.5 % | -11.24 | |
| Mar2020 | 1.69 % | -63.26 | |
| Mar2019 | 4.6 % | - | |
FREDUN PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539730]
| Y-o-Y | 66.83 % |
| 5 Yr CAGR | 20.84 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹24 | 66.83 | |
| Mar2022 | ₹14 | 182.97 | |
| Mar2021 | ₹5.05 | 5.87 | |
| Mar2020 | ₹4.77 | -57.33 | |
| Mar2019 | ₹11 | - | |
FREDUN PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539730]
| Y-o-Y | 39.54 % |
| 5 Yr CAGR | -2.80 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 18.35% | 39.54 | |
| Mar2022 | 13.15% | 37.99 | |
| Mar2021 | 9.53% | -8.01 | |
| Mar2020 | 10.36% | -49.61 | |
| Mar2019 | 20.56% | - | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹845.8 |
| Current MarketCap | : | ₹ 397.5 Cr |
| Updated EOD on | : | Apr 26,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 10.5% |
15.3% |
-3.1% |
| SENSEX | 0.9% |
1.5% |
23.6% |
FREDUN PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about FREDUN PHARMACEUTICALS Financials
How the annual revenues of FREDUN PHARMACEUTICALS have changed ?
The Revenues of FREDUN PHARMACEUTICALS have increased by 22.37% YoY .
How the Earnings per Share (EPS) of FREDUN PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 66.83 % YoY .
Check out Intrinsic Value of Peers of FREDUN PHARMACEUTICALS
Compare Stock Analytics of Peers of FREDUN PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
